Month: August 2019

Pedestrians walk by the American International Group building. Ramin Talaie | Bloomberg | Getty Images Insurer American International Group beat Wall Street estimates for quarterly profit on Wednesday, boosted investment income, sending its shares up 2.7% in extended trading. A strong performance in commercial and personal insurance in regions outside of North America helped the
0 Comments
A person exits the Viacom offices in New York. Lucas Jackson | Reuters Viacom, the owner of MTV, Comedy Central, and Nickelodeon, beat estimates for quarterly revenue on Thursday, helped by a rare growth in domestic advertising revenue. Net income attributable to Viacom rose to $544 million, or $1.35 per share, in the third quarter
0 Comments
President Donald Trump‘s trade war comes with an aggressive and clear-cut strategy but a fuzzy endgame, namely that it’s unclear just what victory would look like. True, there are lofty ambitions: a world without tariffs, a “level playing field” with China where goods would flow freely between the two nations, and the promise of untethered
0 Comments
A pedestrian walks through the parking lot of a CVS Health Corp. store in Oakland, California, Aug. 2, 2019. Michael Short | Bloomberg | Getty Images CVS Health on Wednesday smashed Wall Street’s second-quarter earnings and revenue expectations and raised its full-year forecast. Here’s what the company reported compared with Wall Street estimates, based on
0 Comments
Borut Trdina | Getty Images Wealthy investors are trimming their stock positions, amid anxiety around a trade war and instability in Washington. Members of TIGER 21, an investment club for high-net-worth individuals, reduced their stock allocation to 21% from 22% during the second quarter, according to the group’s quarterly report. TIGER 21, a group of
0 Comments
The Novartis headquarters in Basel, Switzerland. Arnd Wiegmann | Reuters The Food and Drug Administration said Tuesday Novartis‘ application for its $2.1 million gene therapy for spinal muscular atrophy contained errors it knew about before approval. In May, the FDA approved Novartis’ gene therapy, making it the world’s most expensive drug. The therapy, Zolgensma, is
0 Comments
The Trump administration took the trade war up another notch, calling China a currency manipulator and ratcheting up expectations that the White House has other moves it could make to retaliate against China. Last used in the 1990s, the designation was announced by the U.S. Treasury Monday after U.S. markets closed out a turbulent session.
0 Comments